Option Care Health (OPCH) FY2017 results: revenue $1.8 billion, up 95.4% on the year
Option Care Health, Inc. (OPCH) reported revenue of $1.8 billion for fiscal 2017, the year ended 31 December 2017, up 95.4% on the year before. Net income was $4 million, and diluted earnings per share $-0.60. The figures are the company's own, from the 10-K it filed with the SEC on 15 March 2019.
Revenue
$1.8 billion
+95.4% on the year
FY2007FY2017
Operating margin
1.5%
-1.2% a year earlier
FY2007FY2017
Net income
$4 million
FY2007FY2017
Diluted EPS
-$0.60
FY2007FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2011
On the year
Last 8 years
Revenue
1,828
936
1,818
+95.4%
Cost of revenue
548
674
339
-18.6%
Gross profit
446
262
215
+70.2%
Gross margin
24.4%
28.0%
11.8%
Selling, general and administrative
338
n/a
n/a
Operating income
27.3
-11.0
25.6
Operating margin
1.5%
-1.2%
1.4%
Interest expense
n/a
n/a
25.5
Pre-tax income
-67.4
-34.2
0.0
Income tax
-18.6
2.0
0.4
Effective tax rate
n/a
n/a
3954.5%
Net income
3.9
-42.8
7.9
Net margin
0.2%
-4.6%
0.4%
Diluted EPS
-$0.60
-$0.54
$0.14
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2011
On the year
Last 8 years
Operating cash flow
37.9
-42.5
27.0
Capital expenditure
25.0
9.9
0.5
+152.8%
Free cash flow
12.9
-52.4
26.5
Free cash flow margin
0.7%
-5.6%
1.5%
Cash from investing
-24.5
-73.2
-9.9
Cash from financing
-5.2
110
-17.1
Depreciation and amortisation
34.7
22.0
10.0
+57.4%
Share-based compensation
1.5
1.8
4.5
-19.2%
Diluted shares, weighted
n/a
n/a
55m
Shares outstanding at period end
n/a
118m
55m
Balance sheet
$ million
FY2017
FY2016
FY2011
On the year
Last 8 years
Shareholders' equity
n/a
601
215
Debt
n/a
468
293
Other liabilities
n/a
n/a
168
Total liabilities and equity
n/a
605
677
Fixed assets
n/a
32.7
27.0
Goodwill
n/a
366
312
Intangible assets
n/a
31.0
19.6
Cash and equivalents
n/a
9.6
0.0
Receivables
n/a
109
225
Inventory
n/a
36.2
18.0
Other assets
n/a
20.5
74.7
Total assets
n/a
605
677
10-K for the year ended 31 December 2017, filed 15 March 2019: the filing.